…   The placebo effect is when a person experiences benefit from a placebo, which has no active medical treatment. … in research?   Researchers need to know that benefits from a new therapy are from the intervention itself and not just from the idea of …

… partners Roche and Prothena presented additional results from its Phase II PASADENA study of an alpha-synuclein … 2020, the pharmaceutical company Roche announced results from the first part of the PASADENA study, a Phase II … providing now? R/P: In Part two of the study, patients from the placebo arm of the study are now receiving …

… radial stem cell treatments abroad. Bill's story Bill Boras from Melbourne was left a quadriplegic after a car accident … sensation in his body. His only information on it comes from the clinic's website, but with similar treatments years off from even pre-clinical trials in Australia, he says he does …

… disease in the general population. With leadership funding from the Brin Wojcicki Foundation, The Michael J. Fox … research teams funded by MJFF to bring together and learn from people with and without PD who carry mutations in the … the standardized collection of various biosamples from individuals with LRRK2 mutations, and make them …

… as assigned roles may shift and we may need you to move from one role to another.  Thank you again for your … event a success! *We ask volunteers work the full event from 8am to 1pm. If you are not available for the entire …

… I could be most helpful today by sharing some key learnings from our short history. Since our launch in 2000, our … needed at different stages of the process, to move ideas from lab bench to pharmacy shelf. In the first part of the … applied work where scientists home in on discoveries from the “A to F” phase, looking for disease-specific …